With AJ Bell and Embark confirming they are following Transact down the IPO trail and Nucleus reported to being thinking similarly, Tom Ellis looks at what lies behind the sudden bout of floatation fever sweeping the platform market.
Since Axa sold Elevate to Standard Life in May 2016 and Legal & General parted with Cofunds for a hefty fee in August 2016, little merger and acquisition (M&A) business has taken place in the adviser platform...
The US dollar is close to peaking and the risks now seem to be on the downside.
Latest news and analysis
Fallout from Haywood suspension
Songs from writers Johntá Austin, Sean Garrett and Rico Love
Strategic public equity